Treatment for Aortic Valve Thrombosis with Anticoagulation
Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 3,000 (estimated)
- Sponsor
- Cedars-Sinai Medical Center · Other
This trial is looking for people who have had a bioprosthetic aortic valve placed in their heart. Participants will undergo imaging tests to check the valve and may receive anticoagulation treatment to help resolve any blood clot issues.
You may be able to join if
- I have a bioprosthetic aortic valve implanted at least 48 hours ago.
- I am 18 years or older.
- I can provide informed consent and follow the study procedures.
You may not be able to join if
- I have renal insufficiency with creatinine levels above 1.5 mg/dL.
- I have a known allergy to iodinated contrast agents.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis is a prospective study designed to evaluate the structural and functional integrity of transcatheter or surgical bioprosthetic valves with multimodality imaging. The study further aims to confirm resolution of the early bioprosthetic valve thrombotic changes with anticoagulation.
Loading trial locations…